| Takeda Pharma AG - Intuniv 3 mg, Retardtabletten | | 66130 | | 03 | | Intuniv 3 mg | | Retardtabletten | | C02AC02 | | Guanfacine | | 15.09.2017 | | |
| | Composition | | guanfacinum 3 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.04073661 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 39.80 mg, povidonum K 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, E 132, E 172 (flavum), pro compresso. | | Packungsbestandteile | | Delayed release tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 3 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | | | | | | | Hypromellosum | | | | Lactose Monohydrate | 39.8 mg | | | | | | | Polysorbatum 80 | | | | | 30 | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
